TrialArthritis research & therapy2008

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.